MMED · Insider Trading
MiniMed Group, Inc. Common Stock
Every open-market purchase and sale reported by MMED officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Que Dallara | Chief Executive Officer | F | −31,350 | −$569.00K |
| 2026-08-04 | Ali Dianaty | EVP Ch. Prod. & Tech Officer | F | −8,012 | −$145.42K |
| 2026-08-04 | Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | F | −1,762 | −$31.98K |
| 2026-07-29 | Chad Spooner | EVP, Chief Financial Officer | F | −23,301 | −$411.73K |
| 2026-07-29 | Gillian Chandrasena | SVP, Chief HR Officer | F | −2,099 | −$37.09K |
| 2026-07-06 | Gillian Chandrasena | SVP, Chief HR Officer | A | +44,188 | — |
| 2026-07-06 | John Gyurci | VP, Chief Accounting Officer | A | +24,244 | — |
| 2026-07-06 | Ali Dianaty | See Remarks | A | +131,312 | — |
| 2026-07-06 | Que Dallara | Chief Executive Officer | A | +297,618 | — |
| 2026-07-06 | Chad Spooner | EVP, Chief Financial Officer | A | +116,607 | — |
| 2026-07-06 | Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | A | +82,787 | — |
| 2026-03-27 | Que Dallara | Chief Executive Officer | F | −4,809 | −$78.43K |
| 2026-03-13 | John Gyurci | See Remarks | A | +15,322 | — |
| 2026-03-13 | Que Dallara | Chief Executive Officer | A | +621,563 | — |
| 2026-03-13 | Gillian Chandrasena | See Remarks | A | +129,765 | — |
| 2026-03-13 | Chad Spooner | EVP, Chief Financial Officer | A | +269,401 | — |
| 2026-03-13 | Courtney Nelson Wills | See Remarks | A | +55,063 | — |
| 2026-03-13 | Ali Dianaty | See Remarks | A | +191,258 | — |
| 2026-03-11 | Glenn A Eisenberg | Director | A | +13,889 | — |
| 2026-03-11 | Kevin E Lofton | Director | A | +27,778 | — |
| 2026-03-11 | D Keith Grossman | Director | A | +13,889 | — |
| 2026-03-11 | Ali Dianaty | See Remarks | A | +140,152 deriv. | — |
| 2026-03-11 | Que Dallara | Chief Executive Officer | A | +335,860 deriv. | — |
| 2026-03-11 | Timothy A Wicks | Director | A | +13,889 | — |
| 2026-03-11 | Chad Spooner | EVP, Chief Financial Officer | A | +111,954 deriv. | — |
| 2026-03-11 | John Gyurci | See Remarks | A | +28,031 deriv. | — |
| 2026-03-11 | Courtney Nelson Wills | See Remarks | A | +70,077 deriv. | — |
| 2026-03-11 | Gillian Chandrasena | See Remarks | A | +70,077 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Que Dallara | Chief Executive Officer | 884,749 | $16.51M |
| Chad Spooner | EVP, Chief Financial Officer | 362,707 | $6.77M |
| Ali Dianaty | EVP Ch. Prod. & Tech Officer | 315,158 | $5.88M |
| Gillian Chandrasena | SVP, Chief HR Officer | 172,745 | $3.22M |
| Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | 136,384 | $2.54M |
| John Gyurci | VP, Chief Accounting Officer | 39,941 | $745.30K |
| Kevin E Lofton | Director | 27,778 | $518.34K |
| D Keith Grossman | Director | 13,889 | $259.17K |
| Glenn A Eisenberg | Director | 13,889 | $259.17K |
| Timothy A Wicks | Director | 13,889 | $259.17K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MMED quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.